Measurement-Based Care (MBC) leads to a significantly faster time to response and remission compared to standard care in adults with major depressive disorder (MDD) in Pakistan.
MBC integrates structured symptom and side-effect monitoring to inform antidepressant dose adjustments, using limited pharmacotherapy options (paroxetine or mirtazapine).
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
